Filter
1335
Filtered Results: 1335
Text search:
therapeutic
agents
Featured
Recommendations
168
New Publications
325
Language
Document type
No document type
666
Guidelines
289
Studies & Reports
215
Manuals
77
Strategic & Response Plan
29
Training Material
19
Fact sheets
19
Situation Updates
10
Brochures
5
Resource Platforms
3
Infographics
2
Online Courses
1
Countries / Regions
India
86
South Africa
52
Global
48
Kenya
41
Ethiopia
31
Uganda
26
Western and Central Europe
25
Zambia
22
Nigeria
21
Nepal
20
Latin America and the Carribbean
20
Tanzania
20
Ghana
17
Sierra Leone
16
Bangladesh
16
Liberia
14
Rwanda
13
Africa
13
Philippines
12
Namibia
12
Congo, Democratic Republic of
11
Myanmar / Burma
11
Malawi
10
Zimbabwe
10
Mozambique
9
Germany
9
Lesotho
8
Burkina Faso
7
Haiti
7
Cambodia
7
Russia
7
Ukraine
6
West and Central Africa
6
South–East Asia Region
6
East and Southern Africa
6
Brazil
6
Indonesia
6
Eswatini/ Swaziland
6
Cameroon
5
USA
5
Middle East and North Africa
5
Eastern Europe
5
Mali
5
South Sudan
5
Thailand
4
Benin
4
Syria
4
Senegal
4
Guinea
4
North Macedonia
3
Asia
3
Venezuela
3
Eastern Europe and Central Asia
3
France
3
Spain
3
Vietnam
3
Yemen
3
Central African Republic
3
Iraq
3
Tajikistan
2
China
2
Fiji
2
Laos
2
Afghanistan
2
Peru
2
Western Pacific Region
2
Paraguay
2
Gabon
2
Sudan
2
Georgia
2
Angola
2
Libya
2
Bhutan
2
Botswana
2
Madagascar
2
Pakistan
2
Colombia
1
Serbia
1
Turkey
1
Australia
1
Kazakhstan
1
Albania
1
Singapore
1
Estonia
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Armenia
1
Guinea-Bissau
1
Jordan
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Papua New Guinea
1
Sri Lanka
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
511
Clinical Guidelines
196
Public Health
67
Women & Child Health
53
Key Resources
40
Pharmacy & Technologies
23
Capacity Building
13
Toolboxes
AMR
170
Mental Health
96
COVID-19
96
Pharmacy
90
TB
71
HIV
66
NTDs
47
Ebola
40
NCDs
40
Caregiver
38
Rapid Response
36
Refugee
19
Planetary Health
18
Disability
14
Conflict
14
Specific Hazards
8
Natural Hazards
8
Cholera
7
Health Financing Toolbox
4
Global Health Education
4
Social Ethics
3
Zika
3
Polio
3
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
Nosocomial infections, or hospital-acquired infec-tions (HAI), are among the most significant causesof morbidity and mortality in healthcare settingsthroughout the world.Prevention of HAIs iscentral to providing high quality and safe health-care, even in settings with limited resources.Transmi...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
The message contained in this publication is clear: countries need a
public health system that can respond to the deliberate release of
chemical and biological agents. Regrettable though this message may
be, the use of poison gas in the war between Iraq and the Islamic
Republic of Iran in the 19...
Chapter 2 in "Latest Findings in Intellectual and Developmental Disabilities Research" Edited by Üner Tan, ISBN 978-953-307-865-6, 404 pages, Publisher: InTech, Chapters published February 15, 2012 under CC BY 3.0 license | Intellectual and Developmental Disabilities presents reports on a wide rang...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub...
This manual guides trained health care providers through the LEEP procedure to remove precancerous cervical lesions that cannot be treated with cryotherapy in order to prevent cervical cancer. The Standard Operating Procedures describe the equipment, step-by-step procedure, safeguards in practice, a...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Clinical management standard operating procedures.
Ebola virus disease (EVD) is a life-threatening multisystem illness associated with fever and gastrointestinal (GI) symptoms that frequently leads to hypovolaemia, metabolic acidosis, hypoglycaemia, and multi-organ failure. The prolonged 2013–201...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Antimicrobials are widely used in food animal production, and use is rapidly increasing.
In an era of growing demand for animal products, there is an increasing trend towards the industrial production of food animals, especially in lower- and middle-income countries (LMICs). One hallmark of this me...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
